hellocare.ai Raises $47M to Accelerate AI-Assisted Virtual Care and Transform Hospital Rooms into Smart, Connected Care Environments
CLEARWATER, Fla., April 15, 2025 /PRNewswire/ -- hellocare.ai, the leading AI-assisted virtual care delivery platform transforming hospital care models and operations, today announced it has raised $47 million in an oversubscribed funding growth round. The round was led by HealthQuest Capital, with participation from a strategic coalition of forward-thinking health systems and digital health investors, including Bon Secours Mercy Health, UCHealth, OSF Ventures, and LRVHealth.
Already deployed across 70+ health systems, the investment fuels a period of hyper-growth for hellocare.ai, as demand accelerates for its unified virtual care platform. The platform that enables hospitals to deliver AI-assisted Virtual Nursing, Virtual Sitting, Virtual Consultation, Ambient Documentation, Digital Whiteboards, Patient Engagement, and Hospital-at-Home—all through one deeply integrated, enterprise-ready solution. The advancement and convergence of artificial intelligence and immersive virtual to physical care technologies have fueled the demand for smart hospital rooms, representing an opportunity to support healthcare delivery across the continuum of care.
'This raise represents a powerful vote of confidence in our mission and model,' said Labinot Bytyqi, Founder and CEO of hellocare.ai. 'Health systems are asking for a proven, unified virtual care platform to simplify care delivery, drive clinical efficiency, reduce burnout, and increase patient engagement—and that's exactly what we've built. With this funding, we're partnering with some of the leading health systems to scale fast and go deeper into AI to solve healthcare's toughest care delivery and operational challenges.'
'hellocare.ai's technology and vision are very closely aligned with the evolving needs of health systems,' said Randy Scott, Partner at HealthQuest Capital. 'They are solving real problems at scale, with a practical and powerful platform that delivers measurable impact.'
A New Standard for Virtual Care and Patient Engagement
hellocare.ai is the only purpose-built platform on the healthcare market with a fully in-house technology stack—encompassing hardware, software, AI, and a seamless EHR integration engine. This end-to-end approach delivers unmatched speed, customization, and continuous innovation. Paired with AI and flexible hybrid clinical care team models, hellocare.ai empowers health systems to rapidly scale hybrid care, deliver high-quality care from anywhere, and create a truly patient-centric experience—all through a single, unified platform.
Trusted by Leading Health Systems
Already deployed across 70+ health systems, hellocare.ai is replacing fragmented point solutions and delivering meaningful ROI—transforming any hospital room into a smart, connected care environment. In a major milestone, AdventHealth is rolling out hellocare.ai across more than 50 hospitals and over 13,000 patient rooms as part of an enterprise-wide implementation to enhance patient experience, streamline clinical workflows, and drive operational efficiency.
Both Bon Secours Mercy Health and UCHealth are not only investors in this round but also customers of hellocare.ai—actively deploying the platform to reimagine virtual care delivery and elevate patient engagement across their systems. Their dual role highlights the deep alignment between hellocare.ai's innovation roadmap and the real-world needs of modern health systems.
'Our partnership with hellocare.ai will allow us to improve safety, reduce readmissions, optimize staff workflows and improve patient experience in our hospitals,' said Mark Townsend, MD, MHCM, chief clinical digital ventures officer, Bon Secours Mercy Health and Accrete Health Partners. 'Investing in novel digital health technologies enables our health system to be at the forefront of digital transformation, with the intent of making health care as easy as possible for patients and providers.'
About hellocare.ai
hellocare.ai is a leading provider of AI-assisted virtual care solutions. Headquartered in Clearwater, FL, the company supports more than 70 health systems across the U.S. and is rapidly expanding globally. hellocare.ai helps health systems deliver high-quality, patient-centered care while improving clinical efficiency and staff wellbeing. Its fully integrated platform includes AI-Assisted Virtual Nursing, Virtual Sitting, Patient Engagement, Digital Whiteboard, Digital Room Signage, Ambient Documentation, Hospital-at-Home, Remote Patient Monitoring (RPM), and Digital Clinic—seamlessly embedding into existing healthcare EHRs, infrastructure, and care delivery models to power the next generation of healthcare. For more information, visit https://hellocare.ai
About HealthQuest Capital
HealthQuest Capital is a private asset firm that provides capital to transformative healthcare companies. HealthQuest Capital focuses on commercial prospects that drive enhanced patient outcomes and elevate the efficiency of healthcare delivery. With approximately $2 billion in capital under management, the firm focuses on fostering innovation across the healthcare spectrum, including medical technologies, diagnostics, digital health, and innovative services. The HealthQuest Capital team combines decades of investing experience with domain expertise in the various aspects of the healthcare industry. For more information, visit www.healthquestcapital.com
For inquiries, contact:
Mimoza Buonsanti
[email protected]
View original content to download multimedia: https://www.prnewswire.com/news-releases/hellocareai-raises-47m-to-accelerate-ai-assisted-virtual-care-and-transform-hospital-rooms-into-smart-connected-care-environments-302427478.html
SOURCE hellocare
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Xtalks Announces its Life Science Webinar Calendar for August 2025
Upcoming free, educational webinars from Xtalks will feature topics on cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, healthcare, laboratory technology, medical device, patient recruitment & retention, pharma manufacturing & supply chain and preclinical. TORONTO, Aug. 1, 2025 /PRNewswire/ -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field! Visit to see our upcoming webinars: CELL AND GENE THERAPYAugust 22 - How Cell-Free mRNA Templates Support Faster Research with High-Quality and Quick Turnaround CLINICAL TRIALSAugust 7 - Improving Clinical Tech Adoption: Site-Centric ApproachesAugust 13 - Accelerating Clinical Research with Master Protocols: Challenges and Benefits to Complex Trial DesignsAugust 14 - Designing Innovative Trials: Navigating Dose Optimization in Oncology CombinationsAugust 15 - AI in Clinical Trials: Early Use Cases and Innovations COMMERCIALIZATION & HEORAugust 19 - 5 Critical Questions to Ask Before Applying AI to Real-World Data DRUG DISCOVERY & DEVELOPMENTAugust 7 - Oral Dosage Innovation for Pediatric Drug DeliveryAugust 7 - Cancer Drug Discovery: A Synthetic Lethality Approach Using Integrated PlatformsAugust 12 - Radiotracers and ADC Targeting: Scientific Insights for In Vivo Validation and Clinical TransitionAugust 13 - AI in Drug Discovery & Development: Hype, Reality and What Comes NextAugust 21 - Dose Escalation: Optimizing Cohort Management in Early-Phase DevelopmentAugust 26 - AI in Bioprocessing Today — Accelerate. Predict. Deliver. HEALTHCAREAugust 20 - Beyond Diagnosis: The Real-World Impact of AVISE Testing on Lupus, Rheumatoid Arthritis, and Autoimmune Disease Care LABORATORY TECHNOLOGYAugust 6 - Precision Matters: The Critical Role of Accurate Liquid Handling in the Lab MEDICAL DEVICEAugust 25 - Transforming Medical Imaging with AI: Open Tools, Faster Insights PATIENT RECRUITMENT & RETENTIONAugust 20 - Transforming Patient Recruitment: AI and Digital Strategies to Engage the Unreachable 95%August 27 - Enhancing Patient Recruitment in Clinical Research: A Personalized and Engaged Journey PHARMA MANUFACTURING & SUPPLY CHAINAugust 14 - Biofermentation Success Through pH and DO Management PRECLINICALAugust 26 - Advanced In Vivo Efficacy Models for Preclinical Success ABOUT XTALKS Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers. To learn more about Xtalks visit Contact:Ayesha RashidXtalks ( Tel: +1 (416) 977-6555 x371Email: arashid@ View original content to download multimedia: SOURCE Xtalks Inicia sesión para acceder a tu cartera de valores
Yahoo
2 hours ago
- Yahoo
Cool Off This August with Root Beer Ice Cream at Cold Stone Creamery®
SCOTTSDALE, Ariz., Aug. 1, 2025 /PRNewswire/ -- Cold Stone Creamery® ( is bringing nostalgic flavors to the forefront this summer with the launch of its limited-time Root Beer Ice Cream, available now through August 31. Inspired by the classic soda fountain favorite, this flavor offers a refreshing and creamy twist on a beloved American tradition. Root Beer Ice Cream is handcrafted fresh in every store and can be enjoyed on its own or as part of two delicious offerings. The Root Beer Revival Creation™ mixes Root Beer Ice Cream with chocolate chips, caramel, and whipped topping, while the Go With the Float, our take on the classic soda shop root beer float, features Root Beer Ice Cream and root beer topped with whipped topping and a maraschino cherry. "Root Beer Ice Cream is a nostalgic flavor that instantly takes you back in time," said Courtney Maxedon VP of Marketing and Digital Strategy at Kahala Brands™, parent company of Cold Stone Creamery. "We wanted to capture that classic root beer float experience and serve it up in a way that only Cold Stone can - bold, creamy, and full of flavor." Don't miss your chance to experience this limited-time flavor. Whether you're reliving childhood memories or discovering root beer in a whole new way, our Root Beer Ice Cream is the perfect way to cool off your August. Available in stores and online, this ice cream won't be around for long, so grab it while you can! Promotional Flavor: Root Beer Ice Cream Promotional Creation™: Root Beer Revival - Root Beer Ice Cream, Chocolate Chips, Caramel & Whipped Topping Promotional Float: Go With the Float - Root Beer Ice Cream, Root Beer, Whipped Topping & a Maraschino Cherry About Cold Stone CreameryCold Stone Creamery® delivers the Ultimate Ice Cream Experience® through a community of franchisees who are passionate about ice cream. The secret recipe for smooth and creamy ice cream is handcrafted fresh daily in each store, and then customized by combining a variety of mix-ins on a frozen granite stone. Headquartered in Scottsdale, Arizona, Cold Stone Creamery is owned by parent company Kahala Brands™, one of the fastest growing franchising companies in the world with a portfolio of nearly 30 fast-casual and quick-service restaurant brands with approximately 3,000 locations in 35 countries. The Cold Stone Creamery brand operates nearly 1,500 locations globally in approximately 30 countries worldwide. For more information about Cold Stone Creamery, visit View original content to download multimedia: SOURCE Cold Stone Creamery Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025
BELLEVUE, Wash., Aug. 1, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical innovations to improve health and wellness worldwide, today announced that it will host a Virtual Investor Event on Wednesday, August 6, 2025 at 8:00 a.m. Eastern Time (2:00 p.m. Central European Summer Time / 9:00 p.m. Korea Standard Time). The event will provide shareholders and prospective investors with a detailed update of the Company's strategic direction, subsidiary performance, capital allocation, and pipeline R&D. Senior members of the OSRH executive team will be presenting. Event Details Date: Wednesday, August 6, 2025Time: 8:00 a.m. ET / 2:00 p.m. CEST / 9:00 p.m. KSTLocation: Virtual (livestream access)Registration: Opens Monday, August 4 at Available after the event on the OSR Holdings Investor Relations website. Agenda Highlights Corporate overview and strategic vision Subsidiary and R&D pipeline updates: Vaximm: Tailored, Antigen-specific in vivo T-cell Immunotherapies Darnatein: DRT101 – a potent DMOAD candidate Woori IO acquisition: The opportunity for noninvasive CGM Equity Line of Credit (ELOC) financing strategy Blockchain & Tokenization strategy Live Q&A with management "This event is a timely opportunity to engage with our shareholders and the broader investment community as we move into a transformative stage in OSR's growth," said Peter Hwang, CEO of OSRH. "We look forward to showcasing the strength of our platform, the progress we've made, and the catalysts ahead. We are committed to transparency, disciplined execution, and delivering meaningful value to all stakeholders in the coming months."Featured Speakers: Mr. Peter Hwang – Chief Executive Officer Dr. Constance Höfer – Chief Scientific Officer Mr. Tim Smith – Global Investor Relations About OSR Holdings, Inc. OSR Holdings, Inc. (NASDAQ: OSRH) is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness to support global health outcomes. Through its subsidiaries, OSRH is engaged in immuno‑oncology, regenerative biologics, and medical device distribution. OSRH's vision is to acquire and operate a portfolio of innovative healthcare and wellness companies, improving patient care through cutting‑edge research and development. For more information, visit View original content to download multimedia: SOURCE OSR Holdings Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
